Transcription of Pink Book 2020
{{id}} {{{paragraph}}}
Pain Management Tables and Guidelines Dana Farber Cancer Institute/ Brigham & Women's Hospital Benjamin S. Kematick, PharmD, Iman Suliman, PharmD, Annabelle Hood, PharmD, Darin Correll, MD, Kevin M. Dube, PharmD, Victor Phantumvanit, PharmD, Elizabeth Rickerson, MD, Mark Zhang, DO, MMSc, Lida Nabati, MD, Sarah Given, ANP-BC, Bridget Fowler Scullion, PharmD 2020 The BWH/ DFCI Pain Management Tables and Guidelines Committee would like to acknowledge the following people for their contributions to past versions of these tables: Christopher J. Scott, PharmD, Cherlynn Griffin, PharmD, Amanda Dietzek, PharmD, Janet Abrahm, MD, Hallie S. Greenberg, MS-PREP, RN,BC, Elaine Robbins, ANP, ACNP,CCRN, Barbara Reville, DNP, Maureen Lynch, NP, Inna Zinger, NP. Revised by the BWH/DFCI Pain Management Tables and Guidelines Committee in March 2020 Past revisions: 1998, 2000, 2002, 2004, 2007, 2009, 2013, 2017 Dana-Farber Cancer Institute/Brigham and Women's Hospital Pain Management Tables and Guidelines (Pink Book) provides educational information for healthcare professionals at Dana-Farber and Brigham and Women s Hospital.
oxyMORphone, transdermal fentanyl, continuous opioid infusion or methadone. Long Acting opioids can be safely used with non-opioid therapy and short-acting as needed (PRN) opioid therapy. Non-Opioids in the Treatment of Pain 1. Non-opioid therapies including pharmacologic and non-pharmacologic therapies can benefit many patients 2.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}